Don’t Forget the Excipients
How can pharma better ensure data integrity for excipients?
Maryam Mahdi | | Quick Read
The International Pharmaceutical Excipients Council Federation (IPEC) has published a position paper urging pharma stakeholders to create strategies that ensure the quality of critical data for excipients. Though data integrity is an essential part of any GMP application, much of the regulatory guidance currently available does not outline data integrity requirements for inactive drug products.
IPEC suggested several ways excipient suppliers could improve their data integrity, including the ensured maintenance of product life cycles and the use of training and internal auditing to guarantee compliance with documented data integrity controls. Excipient users were also advised to “manage expectations appropriately when auditing excipient suppliers” as their data integrity controls may differ depending on the type of products developed.
The paper is available at https://bit.ly/2A2QYOJ
Enjoy our FREE content!
Log in or register to gain full unlimited access to all content on the The Medicine Maker site. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.